chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The next day (06Oct), I could barely walk as my limbs were very sore; I experienced extreme exhaustion-enough to keep me in bed; On the afternoon (5Oct)that I received the booster dose (#3) of the Pfizer vaccine, I developed fever (102); shivering. The shivering was very intense--more like shaking.; The shivering was very intense-more like shaking.; This is a spontaneous report from a contactable consumer(patient herself). A 69 years non-pregnant old female patient received dose 3 BNT162B2 PFIZER BIONTECH COVID 19 VACCINE mRNA, lot number:3015581A) via unspecified route of administration in Left arm administered on 05 Oct2021 at 10:00AM. Patient medical history include glaucoma and elevated cholesterol from unspecified date. Patient's other medications in two weeks included multivit, fishoil, magnesium, C, D, Bilberry. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6205) via an unspecified route of administration, administered in arm left on 06Mar2021 as dose 2, single and dose 1 of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9264) via an unspecified route of administration, administered in arm left on 13Feb2021 as dose 1, single for covid-19 immunisation. Patient received vaccine at Pharmacy or Drug Store. Patient had not received any other vaccine in 4 weeks. Patient did not have covid prior vaccination. The patient did not tested covid post vaccination. On 05 Oct2021 the in afternoon patient received the booster dose (#3) of the Pfizer vaccine, developed fever (102) and shivering. The shivering was very intense-more like shaking. Patient took Tylenol but the shivering/shaking continued. The next day (06Oct) patient could barely walk as my limbs were very sore. Patient experienced extreme exhaustion-enough to keep me in bed. In the evening, the fever remained at 102.2. The next day (07Oct), the shivering has decreased and the fever came down to almost normal but the body aches and exhaustion continue. Patient had not received treatment for events. The patient underwent body temperature measurement results was 102 on 05Oct2021 and 102.2 on 06Oct2021. The outcome of events were recovering.   Follow-Up (14Oct2021): Follow-up attempts are completed. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a 21-year-old female subject who was vaccinated with FLULAVAL. Medical history included no allergies. There were no concurrent medications. On 13 October 2008 the subject received unspecified dose of FLULAVAL (unknown, unknown arm). In October 20008, less than one week after vaccination with FLULAVAL, the subject experienced injection site redness, injection site pruritis and warm to touch at injection site. The subject was treated with ibuprofen. At the time of reporting the events were unresolved. The healthcare professional considered the injection site pruritis was probably related to vaccination with FLULAVAL. An office manager reported that an adult female reported redness, itching and warm to touch in her arm following FLULAVAL injection on 13 October 2008 the subject received unspecified dose of FLULAVAL (unknown, left deltoid). On 14 October 2008, 1 day after vaccination with FLULAVAL, the subject experienced no difficult breathing, local skin reaction with redness, induration and swelling. The subject actually got flu like symptoms one day after the injection. The subject also noted fever and myalgia with tightness in her neck. The subject's warmness to touch at injection site measured 3 centimeters by 3.5 centimeters. The flu like symptoms for three days after injection. The subject was advised she is probably allergic to thimerasol and she should not receive another flu vaccine. The healthcare professional considered the events were related to vaccination with FLULAVAL.
On 6/1/21 Patient started experiencing fever and chills. Patient tested positive for Covid 19 at doctor's office/
local rxn 1/2 hrs p/recvd 2nd dose of MMR (1st 1 month prior) mild redness @ site of inject, sl warmth to touch;
Patient is a 67 y.o. female with multiple medical comorbidities was admitted for management of COVID-19 pneumonia and acute hypoxic respiratory failure and discharged Yesterday 7/28 , With ABX and steroids And 1 L oxygen upon discharge . Pt comes back this noon to ER stating her stats Overnight with 1 lts O2 was down to 86 . Pt did not try to increase The O2 flow . C/o low O2 sats when getting up and moving around (84-88%) Pt also with c/o worsening dyspnea Hospital Course: (Please include treatment given and significant findings) 67-year-old female with history of hypertension, type 2 diabetes, hypothyroidism asthma was recently hospitalized for COVID pneumonia and was discharged on monitor oxygen. She presented back to ER on 08/02 with complaint of low oxygen saturation at home. She was started on broad-spectrum antibiotics and steroids. Pulmonary was consulted and recommendations were followed. 2D echo shows normal EF. Patient improved clinically during hospital stay. She is currently requiring 2 liters oxygen. Symptoms started on 07/20. She was advised to follow-up with primary care provider and Pulmonary on an outpatient basis. Outpatient sleep study recommended. The remainder of the patient's medical problems were chronic and stable without any further intervention this admission. The patient will continue the current treatments and medications. Patient was clinically and hemodynamically stable at discharge. Patient was seen and examined at bedside earlier today. She denied any complains. Physical Exam: Temp: [98 ?F (36.7 ?C)-98.3 ?F (36.8 ?C)] 98 ?F (36.7 ?C) Heart Rate: [54-80] 74 Resp: [16-18] 18 BP: (115-185)/(71-109) 158/109 GEN: No acute distress CV: Regular rate and rhythm, No murmurs appreciated PULM: Clear to ausculation anteriorly, No rales or wheezing ABD: Bowel sounds normoactive, Soft, Not tender, Not distended SKIN: No rashes appreciated NEURO:No focal deficits
Client unexpectedly collapsed and passed away on 1/13/21 from suspected sudden cardiac death.  Prior to her death, she was in skilled care for rehabilitation following hospitalization from 12/21-12/31/20 for an acute lower GI bleed.  Her hospitalization and skilled care stay were complicated by delirium and she was being treated for delirium with olanzapine (Zyprexa) at time of death.
Day 1: Day of injection:  Soreness at injection site.  Nighttime soreness of entire left arm and sensitivity to touch sufficient to disturb sleep.  Day 2:  Continued arm soreness and sensitivity to touch, bright redness and swelling at injection site; lassitude, retired 2 hours early.  Day 3:  Lessened soreness, restricted to injection site; redness and swelling at injection site.  No effect on day-to-day activities.  Day 4: Slight redness and swelling at injection site.  No effect on day-to-day activities.
PT WAS FULLY VACCINATED FOR COVID19. DOSE 1 - 2/24/21 (LOT 013M20A); DOSE 2 - 3/25/21 (LOT 003A21A). TESTED + 8/28/2021 - S/O 8/26/2021
PATIENT REPORTED THAT SHE HAD BEEN DIAGNOSED WITH SHINGLES AS A RESULT OF GETTING THE ZOSTAVAX VACCINE ON 6/20/11.  SHE CAME TO THE PHARMACY TO FILL AN ACYCLOVIR PRESCRIPTION TO TREAT THE SHINGLES.
Localized swelling and redness at injection site. Induration of 30 mm on left tricep. C/O of itching. Denied pain. Non systemic. No sx of anaphylaxis. Explained signs and symptoms to report. Hydrocortisone 1% given for local application. Apply ice prn. Ibuprofen for discomfort.
Seen in our office 11/23 for rash, covering face, palms, soles, blanching red 2-3mm maculopapular rash nonvesicular or urticarial. ? reaction to MMR. Immuns rec'd 11/8/11.
Wife called to say patients arm was red and prickly. After asking she said it was a little warm too.
pt recv vax & in 1997 lab eval revealed a lack of seroconversion;
The pt was given a full dose of flu pf which is only licensed for 36 months & older the pt is only 4 months.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 83-year-old patient of unknown gender. No information was received regarding medical history, concurrent conditions, or concomitant medications. On an unknown date, the patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2009, the patient was administered ZOSTAVAX by a pharmacist at a pharmacy (dose, route of administration, vaccination site, lot # and expiration date were not provided). On an unspecified date, the patient was treated by a healthcare provider at the hospital for the following injuries resulting from the patient's ZOSTAVAX use: shingles. The outcome of shingles was unknown. The causality assessment between the event of shingles and ZOSTAVAX was reported as related. The causality assessment for product quality issue was not reported.
I CAME DOWN WITH A SLIGHT CASE OF COVID-19, SORE THROAT AND COUGHING, TOOK PAXLOVID FOR 4 DAYS (UNTIL I SHOWED SIGNS OF AN ALLERGIC REACTION TO PAXLOVID), AND HAVE BEEN SLOWLY IMPROVING SINCE THE ONSET OF THE DISEASE.
Patient complanis of left wrist/lower arm pain since receiving the flu vaccine on 11-10-08. Swelling noted, no c/o fevers.  Has received the flu vaccine for 5 years and has never had a reaction like this before.  On exam, pt had slight ecchymosis/swelling at site. Lower arm mildly swelled/tender laterally.  Wrist tender throughout, mildly swollen and no redness.  Was treated with Naproxen 500mg. 1 p.o. BID w/food.
11:30pm constant body shaking and shivering. Midnight fever of 102.6 degrees with vomiting. This lasted for 4 hours. Fever rise to 102.8 and constant with TYELENOL unit 9:30am.
Due Date: 8/6/2021 Baby delivered:  Baby weight: 3lbs  Baby is still in the hospital in Neonatal Intensive Care Unit: from 06/01/2021 to  Present
One giant "hive" allergic reaction bump around the injection site (1st Moderna booster; 3rd overall COVID vaccine injection), 4.5 days after administration. Approximately 3.5 inches in diameter, in a round circular shape. No other hives/bumps or any superficial reactions on any other part of my body. I just wanted to document this allergic reaction in case your office deems it significant. I had no such reaction to either the first or second dose only the booster.
"Administered - 09:58 Adverse event started - 10:15  Patient had hives, flushing/sweating. BP 118/54, HR 83, RR 18, O2 92%. Given 0.3mg EpiPen at 10:25, 911 called at 10:30, patient taken to emergency room."
21 hours after 1st dose, I became suddenly nauseated. This passed and then came a flood of severe flu-like symptoms: fever, chills, horrific headache, body aches, muscle weakness, fatigue. Symptoms lasted approx. 41 hours. Through the night after the shot, I couldn't believe I didn't go to an E.R. I thought I was going to die, the symptoms were that terrible.
Left arm swollen from deltoid around to bicep, causing pain  into back and left neck. Continuous nausea, chills , fatigue, headache ,. Body ache, lasted until 3/19, 3-4 pm
NO ADVERSE EVENT AT THE TIME OF THIS REPORT; GAVE FIRST ROTATEQ VACCINATION TO THE PATIENT THAT WAS 16 WEEKS OLD, ONE WEEK PAST THE  RECOMMENDED AGE LIMIT OF 15 WEEKS.
The vial was initially stored in the refrigerator on 06-JUL-2022 and was administered from 19-Sep-2022 until 09-Nov-2022; No adverse event; Adult patient received expired Monovalent booster dose of Moderna COVID-19 vaccine.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Monovalent booster dose of Moderna COVID-19 vaccine.), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 06-JUL-2022 and was administered from 19-Sep-2022 until 09-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Monovalent booster dose of Moderna COVID-19 vaccine.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 06-JUL-2022 and was administered from 19-Sep-2022 until 09-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Monovalent booster dose of Moderna COVID-19 vaccine.), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 06-JUL-2022 and was administered from 19-Sep-2022 until 09-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Monovalent booster dose of Moderna COVID-19 vaccine.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 06-JUL-2022 and was administered from 19-Sep-2022 until 09-Nov-2022).    No concomitant information was reported. It was reported that monovalent vials of Moderna COVID-19 vaccine in the freezer moved to the refrigerator on 06-JUL-2022 and beyond use date was 05-AUG-2022. The unknown vial did not underwent any temperature excursions. This case is reported for 3rd patient out of 12 patients. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-720531 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-720531:
rash; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) and MYALGIA (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced RASH (rash) and MYALGIA (sore arm). At the time of the report, RASH (rash) and MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Headache; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer, the patient, reported a female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), first dose, via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a headache. The clinical outcome of the headache was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
pt recvd vax; pt noticed hair breakage/loss; pt consulted MD; due to menopause; perms hair every 3 mo;
Patient had previously received one dose of Moderna Monovalent COVID-19 vaccine on 4/13/23. Patient returned to office today to receive second dose in series. Patient was given Moderna Bivalent (6m-5y)-PF COVID-19 booster (dark pink cap/yellow label) 0.2 mL. Upon reviewing the updated recommendations, patient should have received the Moderna Bivalent (blue cap/gray label) 0.25 mL. Our provider, Dr., contacted Moderna to determine the correct next steps. Since patient was under-dosed, Moderna recommended patient come back into office (same day) to receive the correct Moderna Bivalent dose (blue cap/gray label). Contacted mother, informed her of situation, and patient came in today to receive the correct dose. No adverse reactions reported by mother.
Adverse Event: Allergic reaction started 1 hour after vaccination (Rash, itchy, hives on upper right chest)   Large swelling/bump still in arm 5 days after injection  Assistant gave the vaccine too high above the deltoid muscle and rather inserted close to shoulder causing SIRVA (Shoulder Injury Related to Vaccine Administration). Cannot lift right arm without pain or discomfort
Noted itching on trunk and swelling at site of injection - lasted 4 or 5 days. Symptoms: Urticaria Pruritus.
her right hand and sometimes the back of her bottom, they go numb; right arm goes numb periodically for hours, and occasionally at night; numbness on my backside; tingling; Her arm started to ache and got really bad; she experienced a freezing feeling on the right side of her body.; This is a spontaneous report from a Pfizer sponsored program COVAX US Support. A contactable female reporter reported that, A 80 years old female received second dose of bnt162b2 (BNT162B2, Formulation was Solution for injection, Lot Number EL9264), dose 2 via an unspecified route on 09Feb2021, DOSE 2, SINGLE as single dose for COVID-19 immunization (age at time of vaccination 80 years). The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (BNT162B2, Formulation was Solution for injection, Lot Number EL3247), dose 1 via an unspecified route on an unspecified date as single dose for COVID-19 immunization. On an unspecified date in 2021 the patient had right arm goes numb periodically for hours, and occasionally at night and had numbness on her backside she also had tingling, eight days later, she had trouble with her right hand. Her arm started to ache and got bad. She mentioned she could not pick anything, and her hand had a hard time gripping thing. n an unspecified date in 2021 she experienced a freezing feeling on the right side of her body. She wants to know if this is due to the vaccine. On19Feb2021 she started having trouble with her right hand and sometimes the back of her bottom, they go numb and today it has lasted longer she wonders if it is because of the vaccine, will it go away on its own or does she need to see her doctor. She says her bottom tingles, like in the back. She says her foot is fine, but she wants to know is that a result of the second shot she got, the Pfizer shot, will it go away on its own or should she do something about it. The outcome of all vents was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient came into the Clinic for a Covid-19 vaccine (moderna). Patient received first dose and had a lightheaded episode. Patient did say he is very anxious because he gets nervous around medical staff. Patient was transferred to high monitoring area and kept there for 1 - 2 hours. Vital signs on 03/19/21 at 10:25 ? BP - 120/79, pulse ? 68, O2 ? 98%, RR ? 20, capillary refill - <2 secs. Patient was given ammonia inhaler to regain awareness. Glucose level ? 5.6 mmol/L. Repeat vitals ? BP ? 106/68, pulse 86, o2 ? 98%, RR ? 18. Patient was given 100 ml water. Over the course of 1 hour patient regained all normal ability
Developed a cough and fatigue day after shot. Thought it was symptoms and would go away. They persisted. Went and got tested for COVID on 1/15/21 and tested positive. Took oral steroids and azythromycin antibiotics but did not help. Was hospitalized with Covid Pneumonia on 1/19/21 and received steroids and Remdesivir. Was released from the hospital on 1/27/21. I CANNOT EMPHASIZE ENOUGHT THAT THERE SHOULD BE AN EMPHASIS MADE FOR PEOPLE TO GET TESTED FOR COVID BEFORE GETTING THE VACCINE.  I WAS THE 9TH PERSON AT THE HOSPITAL WITH THE SAME ISSUE.
Patient acquired an appointment for "booster" dose for Covid 19 vaccine.  He did not inform anyone that his first dose was given at another site or that the first dose given was Moderna product.  When he presented his CDC card to receive for the second dose, it was noted that he had previously been vaccinated elsewhere with another product.  Patient was observed for 30 minutes without any indication of a vaccine reaction.
Headache, muscle pain, joint pain,  tremors, chills, insomnia, sore left arm
Child complained "feels zig-zaggy in his head and tummy", was pale and was laying down on the bus and on the floor during his field trip, at which time the school called that he may need to go home.
For two days afterward: vomiting, chills, fever, rash on trunk and back.  Fourth day afterward to date:  no rash, BUT SEVERE ITCHING ON TRUNK, BACK AND INNER THIGHS.
Right breast pink/red/soar for 3 days.  Areola was painful and  red/pink.
Fatigue, muscle soreness, headache, injection site soreness. No treatment. Symptoms significantly better with 48 hours.
Patient reports rash, swelling, pain and itching at and around the injection site. The patient was given the PREVNAR 13 on 10-12-17 and should have been given the PNEUMOVAX on or after 10-12-18. There should have been a year between the 2 vaccines.
Was asleep and was awakened by severe dizziness and nausea.  Went to bathroom and had numerous sessions of vomiting along with dizziness so bad I couldn?t keep my eyes open and could not sit down or walk. The vomiting was so severe in nature it caused blood vessels to break under the skin of my face.
Patient called the pharmacy on 10/27/18 and reported "very tired" and signficant "loss of appetite". When asked, patient could not recall whether symptom onset was immediate or delayed.... just reported feeling very lethargic that has prolonged for "a week or so". Patient recieved vaccine on 10/15/18.
soreness @ site, immed p/vax;no fever, but extreme muscle aches & soreness for 1 wk;no diff w/breathing but throat feels weird as if chocking;
No adverse event, however this was the 2nd dose with the previous one administered 2/23/2016.  This dose of pneumococcal vaccine should have been PPSV23.
Patient had been evaluated by me for RUQ pain and elevated LFTs since around Oct2022.  Initially thought to be related to heavy alcohol use, she discontinued use.  We then discontinued crestor and zetia.  At this point she received her immunization with the bivalent covid booster.  Then we checked several more labs, LFTs continued to rise and positive autoimmune markers suggesting autoimmune hepatitis.  She was then referred to hepatology.  Repeat LFTs now down trending a bit.
Nausea, muscle pain throughout body for the first 12 hours Unusually delirious dreams Vomiting second night After vomiting and normal sleep, rapid recovery
Information has been received from a physician concerning a 10 year old male who on 03-AUG-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot # 657194/0364U). On 04-AUG-2007 the patient experienced a "severe shot reaction and erythema". The patient was taken to the emergency room but was not hospitalized. Subsequently, the patient recovered from all adverse experiences. A product quality complaint was not involved. Additional information has been requested.
soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN (soreness) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (soreness). At the time of the report, PAIN (soreness) outcome was unknown. Not Provided          No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable